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Background: Although modest anemia protects against cerebral spasm, it is unclear
whether the same is true for coronary spasm. Although women have higher platelet counts
than men with coronary artery disease (CAD), this gender disparity has not been evaluated
in coronary spasm. We sought to determine the roles that hemoglobin, platelet, and
high-sensitivity C-reactive protein (hsCRP) play in patients with coronary spasm.
Methods: Patients (337 women and 532 men) undergoing diagnostic coronary angiog-
raphy with proven coronary spasm but without obstructive CAD were evaluated at
long-term follow-up (mean, 88 months).
Results: Among women with high hemoglobin levels, the odds ratios [OR] from the
lowest to the highest tertiles of hsCRP were 1.21, 2.15, and 5.93 (p  0.009). In women
with low hemoglobin levels, an elevated risk was found from the middle to the highest
tertiles of hsCRP (OR, 0.59 to 3.85) (p  0.004) (Fig. 1). This relationship was not
observed in men. In men, platelet count was the most significant risk factor for coronary
spasm (p  0.004). The highest likelihood of developing coronary spasm was found
among women with the highest hsCRP tertile and low platelet counts (OR  8.77) and
among men with the highest hsCRP tertile and high platelet counts (OR  4.58).
Conclusions: There are positive interactions among hemoglobin, platelet, and hsCRP in
women with this disease, but not in men. While hemoglobin is a modifier in the
development of coronary spasm in women, platelet count is an independent risk factor for
men.
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Background: The influence of myocardial bridge (MB) on the mechanical and biological
response post stenting has not been evaluated among different stent materials. We
hypothesized that a MB potentially impacts chronic stent recoil patterns among the
stainless steel (SS)-based and cobalt-chromium (CoCr)-based drug-eluting stents (DES).
Methods: A total of 300 DES (143 SS: 157 CoCr) in LAD were analyzed. Volumetric
IVUS was performed at baseline and 8-month follow-up (FU) regardless of symptoms.
Volume index (VI) was defined as volume divided by stent length. MB was defined as an
echolucent band surrounding the artery. Diffuse chronic stent recoil was defined as10%
decrease in stent volume index (SVI) during FU. Focal chronic stent recoil was defined
as 20% stent area decrease in 3 consecutive 1-mm segments.
Results: MB was found within or5-mm adjacent to the stent in 81 lesions (MB-stent).
Compared with the non-MB-stent, the incidence of chronic stent recoil was higher in the
MB-stent (Diffuse: 9.9 vs.1.4%, p0.001; Focal: 7.4 vs. 2.7%, p0.067). The maximum
SVI decrease along the stented segment was also greater in the MB-stent (Figure). The 2
stent materials, however, showed similar incidences and degrees of chronic recoil within
the MB- and non-MB-stent groups. The materials also had no effect on the minimum
lumen area and neointimal encroachment at FU when stratified by MB.
Conclusions: MB was associated with a higher incidence and degree of chronic stent
recoil. Even in the presence of MB, however, similar lumen patency could be achieved
with SS- vs. CoCr-based DES.
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Background: In Japan, approximately 40% of patients of angina pectoris have been
postulated to be vasospastic angina. Despite a typical clinical presentation with exercise-
related anginal symptoms (chest pain or dyspnea) with or without occasional attacks of
resting chest pain suggestive of coronary artery disease, nearly half of the patients are
given a diagnosis of noncardiac chest pain, and some are considered to have microvas-
cular angina because of normal or “near” normal coronary arteriograms. Many of these
patients however, we speculate that abnormal coronary vasomotion might also represent
a plausible explanation for the symptoms of the patient. The aimed of this study was to
determine the prevalence of epicardial coronary spasm in Japanese patients with anginal
symptoms despite angiographically normal coronary arteries, and to evaluate the risk of
that.
Methods: This was a retrospective study in consecutive patient (51% men, mean age
6612) with angina-like chest pain and unobstructed coronary arteries. Patients with
normal coronary arteries or only minimal irregularities (20%narrowings) on baseline
diagnostic angiography underwent standardized intracoronary Ergonovine (ERG) provo-
cation for the assessment of coronary vasomotor function. We defined epicardial coronary
artery spasm as diameter reduction of 75% as compared with that after administration
of ISDN
Results: 778 patients underwent intracoronary Ergonovine (ERG) testing, 321 patients
(41%) with epicardial spasm (75% diameter reduction with reproduction of the
symptoms or EKG change). Hypereuremia (46.2% vs 37.6 %, p0.018) and Smoking
(43.8% vs 38.6%, p0.016) was strong risk factor for the spasm.
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Conclusions: The ERG test triggered epicardial coronary spasm in more than 40% of
Japanese patients who underwent diagnostic angiography for assessment of stable angina
and unobstructed coronary arteries. Our results suggest that abnormal coronary vasomo-
tion plays pathogenic role in this setting and that the ERG test might be useful to identify
patients with cardiac symptoms, despite normal coronaries.
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Background: We assume that patients (pt) showing positive acetylcholine (Ach)
provocation test to lower Ach dose may more vulnerable to CAS. We investigated
whether there are differences in angiographic characteristics according to Ach dose
causing significant CAS during intracoronary Ach provocation test.
Methods: A total 1730 consecutive pts underwent Ach provocation test by incremental
doses of 20, 50, 100 were enrolled. Significant CAS was defined as focal or diffuse severe
transient luminal narrowing (70%) with/without chest pain or ST-T change on ECG.
Angiographic characteristics were compared between the Low dose group (20 & 50 ug,
n716) and High dose group (100 ug, n1014) among pts with positive Ach provocation
test.
Results: Baseline clinical characteristics were similar between the two groups except the
Low dose group had more elderly ( 50 years), diabetes mellitus and previous myocardial
infarction (MI). During the Ach provocation test, the incidence of atrio-ventricular (AV)
block, severe CAS (70% stenosis by QCA), multi-vessel spasm and diffuse spasm were
more frequent in low dose group (Table).
Conclusions: In our study, we found that pts showing significant CAS to lower Ach dose
showed more chance to have severe, diffuse and mulitvessel spasm during the test. Special
care with intensive medical therapy should be considered who showed significant Ach
response to lower Ach dose as compared with those responded to higher Ach dose.
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Background: Beta blockers (BB) are widely used to control hypertension. It is well
known that BB may lead to significant vasospasm. However, the impact of chronic
administration of BB on clinical and angiographic characteristics during acetylcholine
(Ach) provocation test is not clarified yet.
Methods: A total 3034 consecutive patients (pts) underwent coronary angiography with
Ach provocation test from January 2004 to August 2010 were enrolled for this study. Ach
was injected in incremental doses of 20, 50, 100g into the left coronary artery.
Significant coronary artery spasm (CAS) was defined as focal or diffuse severe transient
luminal narrowing (70%) with/without chest pain or ST-T change on ECG. A total 1394
pts (45.9%) showed positive provocation tests. Among the (	) provocation test pts, we
compared the clinical and angiographic characteristics of patients with beta-blocker to
those without beta-blocker in pts with myocardial infarction.
Results: The baseline clinical and procedural characteristics are well balanced between the
two groups. There was no difference in the incidence of myocardial bridges, chest pain,
ischemic ECG changes and atrioventricular (AV) block on ECG, incidence of baseline spasm,
severe vasospasm, multi-vessel involvements during the Ach provocation test were similar in
both groups
Conclusions: The use of beta blocker in pts with vasospastic angina was not associated
with worse clinical and angiographic parameters during the Ach provocation test. BB may
be safely used in pts with vasospastic angina.
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Background: The recent study has shown that an implantation of sirolimus-eluting stent
(SES) is associated with late restenosis, i.e., late catch-up phenomenon. We investigated
long-term angiographic outcome in patients with vasospastic angina (VSA) treated with the
SES.
Methods: Subjects were patients who had undergone an ergonovine-provocation test for
chest pain, and were subsequently treated with an SES or bare-metal stent (BMS) because of
a progression of coronary artery stenosis. Patients were divided into four groups: SES with
vasospasm (SES-V, n26); SES without vasospasm (SES-NV, n53); BMS with vasospasm
(BMS-V, n28); and BMS without vasospasm (BMS-NV, n46). Coronary angiography
was performed at 8 months (mid-term follow-up) and 20 months (long-term follow-up) after
the implantation of the stent.
Results: As shown in the figure, the SES implantation was associated with a reduction
of minimum lumen diameter (MLD) at the long-term follow-up, indicating late catch-up
phenomenon. This phenomenon was more obvious in patients with VSA than in those
without (p0.05). Both BMS groups showed a reduction in MLD at the mid-term
follow-up compared with immediately after the intervention. This reduction had regressed
at the long-term follow-up, and that was unrelated to VSA. The rate of stent edge
restenosis compared with stent body restenosis in the SES-V group (87.3%) was higher
than that in the SES-NV group (25.0%, p0.05), suggesting the association of vasospasm
with stent restenosis.
Conclusions: The SES implantation may be associated with high rate of late restenosis
in patients with vasospastic angina.
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Background: Spontaneous coronary artery dissection (SCAD) is a rare cause of
ischemic disease.It occurs frequently in young population with predilection for women-
.Real incidence is probably underestimated.
Methods: we analyzed angiographic aspects and risk factors of consecutive Pts
underwent coronary angiography and discharged by our Division with diagnosis of SCAD
from January 1999 to June 2008.
Results: We observed an angiographic aspect of SCAD in 33/10073 pts(0.33%): 21
women(64%).Mean age 50.8 yy.The cause of admission:STEMI in 9 Pts
(27.7%),NSTEMI in 16(48.3%),subacute myocardial infarction in 2(6%), angina or
positive stress test in 6(18%). One vessel disease in 31 Pts.SCAD of anterior descending
TUESDAY, OCTOBER 23, 8:00 AM–10:00 AMwww.jacc.tctabstracts2012.com
JACC Vol 60/17/Suppl B | October 22–26, 2012 | TCT Abstracts/POSTER/Unusual Coronary Pathology: Spasm, Spontaneous Dissection B123
P
O
ST
E
R
S
